Calliditas Therapeutics AB (publ) (CALT)
USD 40.0
(-0.1%)
USD 40.0
(-0.1%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 979.13 Million SEK | 34.34% |
| 2022 | 728.82 Million SEK | 241.82% |
| 2021 | 213.21 Million SEK | 4354.99% |
| 2020 | 4.78 Million SEK | -21.15% |
| 2019 | 6.07 Million SEK | 0.0% |
| 2018 | - SEK | -100.0% |
| 2017 | 470 Thousand SEK | -98.43% |
| 2016 | 30 Million SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.01 Billion SEK | 3.83% |
| 2024 Q2 | 1 Billion SEK | -0.82% |
| 2023 Q2 | 779.56 Million SEK | 4.37% |
| 2023 FY | 979.13 Million SEK | 34.34% |
| 2023 Q4 | 979.13 Million SEK | 27.13% |
| 2023 Q3 | 770.16 Million SEK | -1.21% |
| 2023 Q1 | 746.89 Million SEK | 2.48% |
| 2022 Q4 | 728.82 Million SEK | 55.96% |
| 2022 Q3 | 467.31 Million SEK | 2.03% |
| 2022 Q2 | 458.02 Million SEK | 113.54% |
| 2022 Q1 | 214.49 Million SEK | 0.6% |
| 2022 FY | 728.82 Million SEK | 241.82% |
| 2021 Q3 | 187.42 Million SEK | 5288.93% |
| 2021 Q4 | 213.21 Million SEK | 13.76% |
| 2021 FY | 213.21 Million SEK | 4354.99% |
| 2021 Q2 | 3.47 Million SEK | 163.68% |
| 2021 Q1 | 1.31 Million SEK | 50.23% |
| 2020 Q1 | 2.33 Million SEK | -61.48% |
| 2020 Q4 | 878 Thousand SEK | -15.09% |
| 2020 Q3 | 1.03 Million SEK | -38.12% |
| 2020 Q2 | 1.67 Million SEK | -28.53% |
| 2020 FY | 4.78 Million SEK | -21.15% |
| 2019 Q2 | 4.86 Million SEK | 0.0% |
| 2019 Q3 | 4.21 Million SEK | -13.46% |
| 2019 Q4 | 6.07 Million SEK | 44.18% |
| 2019 FY | 6.07 Million SEK | 0.0% |
| 2019 Q1 | - SEK | 0.0% |
| 2018 Q4 | - SEK | 0.0% |
| 2018 FY | - SEK | -100.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q2 | - SEK | 0.0% |
| 2018 Q1 | - SEK | -100.0% |
| 2017 Q4 | 470 Thousand SEK | 0.0% |
| 2017 FY | 470 Thousand SEK | -98.43% |
| 2017 Q1 | - SEK | 0.0% |
| 2016 FY | 30 Million SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Absci Corporation | 15.95 Million USD | -6036.072% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -326.764% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 63.501% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -325502.732% |
| Apollomics, Inc. | 4.66 Million USD | -20906.93% |
| 180 Life Sciences Corp. | 1.32 Million USD | -74072.865% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 44.95 Million USD | -2077.981% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -7445.723% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -865.767% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -4510.071% |
| Chimerix, Inc. | 2.14 Million USD | -45568.517% |
| CRISPR Therapeutics AG | 238.63 Million USD | -310.311% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -406.819% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -17803.328% |
| Fortress Biotech, Inc. | 88.59 Million USD | -1005.216% |
| Fortress Biotech, Inc. | 88.59 Million USD | -1005.216% |
| Gritstone bio, Inc. | 104.77 Million USD | -834.51% |
| Allakos Inc. | 41.46 Million USD | -2261.348% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -44507.426% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -2168.244% |
| Cytokinetics, Incorporated | 755.77 Million USD | -29.554% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -9913.633% |
| Innoviva, Inc. | 449.07 Million USD | -118.033% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -1774817.067% |
| NLS Pharmaceutics AG | 1.63 Million USD | -59831.776% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -14078.005% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -337948.218% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -162276.949% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -6969.552% |
| ImmuCell Corporation | 11.96 Million USD | -8080.368% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -33992.375% |
| Incyte Corporation | 38.28 Million USD | -2457.351% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -3141.17% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -597052.476% |
| Mustang Bio, Inc. | 2.49 Million USD | -39096.677% |
| MiMedx Group, Inc. | 48.09 Million USD | -1935.662% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 33.97 Million USD | -2782.261% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 5.95 Million USD | -16350.487% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -787.233% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | -60.26% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -1093.82% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -482231.527% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -689430.282% |
| NextCure, Inc. | 6.6 Million USD | -14724.118% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -57939.893% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 9.88 Million USD | -9804.467% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -307803.459% |
| Opthea Limited | 200.62 Million USD | -388.032% |
| Ovid Therapeutics Inc. | 46 Million USD | -2028.47% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -12686.76% |
| PDS Biotechnology Corporation | 23.85 Million USD | -4005.101% |
| Precigen, Inc. | 7.09 Million USD | -13696.435% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -7082.08% |
| PureTech Health plc | 25.51 Million USD | -3737.931% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -3809.963% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 63.775% |
| Replimune Group, Inc. | 75.86 Million USD | -1190.557% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -1516.291% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -217209.37% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -1013.36% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -2469.633% |
| Solid Biosciences Inc. | 26.26 Million USD | -3627.9% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -59785.81% |
| SciSparc Ltd. | 76 Thousand USD | -1288232.895% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -435.78% |
| TG Therapeutics, Inc. | 110.79 Million USD | -783.734% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -9877.917% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -173197.876% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -141.89% |
| UroGen Pharma Ltd. | 100.21 Million USD | -877.042% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -2051.468% |
| XOMA Corporation | 124.45 Million USD | -686.768% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -2039.106% |
| AbCellera Biologics Inc. | 77.38 Million USD | -1165.357% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -206033.263% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -4588.384% |
| Precision BioSciences, Inc. | 31.26 Million USD | -3031.422% |
| Dyadic International, Inc. | 136.92 Thousand USD | -714966.202% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -619604.43% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -17849.276% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -457438.785% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -7780.98% |
| IGM Biosciences, Inc. | 40.5 Million USD | -2317.254% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -1580.021% |
| Acelyrin, Inc. | 1.19 Million USD | -81904.439% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -18032.093% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -15782.125% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -157316.122% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -3140.445% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -1477.339% |
| Senti Biosciences, Inc. | 37.66 Million USD | -2499.514% |
| Mesoblast Limited | 118.92 Million USD | -723.334% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -1056.356% |
| ChromaDex Corporation | 3.27 Million USD | -29778.944% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -839.829% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -3364.854% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -327.213% |
| Novavax, Inc. | 280.63 Million USD | -248.899% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -845.693% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -1450.07% |
| Celcuity Inc. | 37.44 Million USD | -2514.767% |
| ContextLogic Inc. | 6 Million USD | -16218.883% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -604.26% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -14828.084% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 83.109% |
| Amarin Corporation plc | 8.73 Million USD | -11106.741% |
| AnaptysBio, Inc. | 17.81 Million USD | -5396.424% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -18042.172% |
| Aptorum Group Limited | 3.36 Million USD | -29020.089% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -8837.773% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -750.156% |
| Ardelyx, Inc. | 55.98 Million USD | -1649.014% |
| Celularity Inc. | 65.41 Million USD | -1396.756% |
| Omeros Corporation | 338.28 Million USD | -189.444% |
| Humacyte, Inc. | 58.1 Million USD | -1585.081% |
| Immunocore Holdings plc | 84.03 Million USD | -1065.191% |
| IO Biotech, Inc. | 2.49 Million USD | -39159.543% |
| GT Biopharma, Inc. | 58 Thousand USD | -1688060.345% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -19412.415% |
| Summit Therapeutics Inc. | 106.09 Million USD | -822.848% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 8.75 Million USD | -11082.423% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -748.866% |
| Evogene Ltd. | 1.13 Million USD | -85939.807% |
| CorMedix Inc. | 667.63 Thousand USD | -146557.59% |
| BioLineRx Ltd. | 11.59 Million USD | -8347.356% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -46085.519% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -1506258.462% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -135.921% |
| scPharmaceuticals Inc. | 40.26 Million USD | -2331.481% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -8948.452% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -648332.45% |
| NLS Pharmaceutics AG | 1.63 Million USD | -59831.776% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -3659.678% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -280453.868% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -320927.213% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -14225.282% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -100530.319% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -2653.834% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 5.31 Million USD | -18311.175% |
| bluebird bio, Inc. | 330.32 Million USD | -196.414% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 13.647% |
| DBV Technologies S.A. | 14.38 Million USD | -6708.518% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -9838.419% |
| Galecto, Inc. | 249 Thousand USD | -393126.104% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -15672.117% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -21143.936% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -365.941% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -121019.567% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -375.501% |
| ADMA Biologics, Inc. | 141.41 Million USD | -592.368% |
| Clene Inc. | 32.16 Million USD | -2944.473% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -1832.296% |
| Aptose Biosciences Inc. | 1 Million USD | -96862.486% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -11311510.444% |
| Soligenix, Inc. | 3.49 Million USD | -27918.77% |
| Century Therapeutics, Inc. | 48.17 Million USD | -1932.619% |
| Kura Oncology, Inc. | 17.2 Million USD | -5592.634% |
| Surrozen, Inc. | 3.37 Million USD | -28877.005% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -959.289% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -45441.07% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -6906.82% |
| Autolus Therapeutics plc | 52.96 Million USD | -1748.572% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -2240.016% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -3462.427% |
| GRI Bio, Inc. | 14 Thousand USD | -6993707.143% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -3889.622% |
| INmune Bio, Inc. | 10.43 Million USD | -9281.364% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -445.089% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -16475.643% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -1198642.654% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -195373.575% |
| Jaguar Health, Inc. | 35.86 Million USD | -2630.432% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -118318.105% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -1791.131% |
| Clearside Biomedical, Inc. | 43 Million USD | -2177.001% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -1591.894% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -103.629% |
| Verastem, Inc. | 41.55 Million USD | -2256.121% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -8510.033% |
| Histogen Inc. | 4.62 Million USD | -21084.184% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -1611.621% |
| Surrozen, Inc. | 3.37 Million USD | -28877.005% |
| Organovo Holdings, Inc. | 1.39 Million USD | -70139.096% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -4586003.044% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -1057.532% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -468339.862% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -603122.706% |
| Kronos Bio, Inc. | 28.27 Million USD | -3363.26% |
| Turnstone Biologics Corp. | 3.21 Million USD | -30364.624% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -396310.121% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -1335.048% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -903.138% |
| Exelixis, Inc. | 189.94 Million USD | -415.485% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -3098.318% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -782.674% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -35044.76% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -1218818.683% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -2003446.143% |
| Avid Bioservices, Inc. | 207.83 Million USD | -371.113% |
| Insmed Incorporated | 1.2 Billion USD | 18.676% |
| MediWound Ltd. | 6.71 Million USD | -14489.972% |
| OmniAb, Inc. | 25.56 Million USD | -3730.574% |
| Alector, Inc. | 38.91 Million USD | -2415.887% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -357.676% |
| Zai Lab Limited | 15.15 Million USD | -6362.498% |
| AlloVir, Inc. | 27.42 Million USD | -3469.7% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -104.654% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -9487.124% |
| Aura Biosciences, Inc. | 19.55 Million USD | -4906.56% |
| Immunic, Inc. | 1.33 Million USD | -73298.276% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -2985.633% |
| Veracyte, Inc. | 12.63 Million USD | -7652.439% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -51.835% |
| FibroGen, Inc. | 170.45 Million USD | -474.423% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -10682.216% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -27426.933% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -480076.646% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -2646205.405% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -23009.11% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 41.649% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -13281.618% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -35044.76% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -6678.822% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -107972.075% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -3542.472% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -2072.327% |
| Agenus Inc. | 350.24 Million USD | -179.556% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -68901.621% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -2064.5% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -2168.139% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -1930.175% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | -15.367% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -95202.21% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -1279.527% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -6898117.557% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -249677.552% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -417492.367% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -255548.303% |
| Ainos, Inc. | 5.96 Million USD | -16318.61% |
| Pluri Inc. | 29.61 Million USD | -3206.541% |
| Prothena Corporation plc | 11.83 Million USD | -8173.198% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -3780.059% |
| Rallybio Corporation | 392 Thousand USD | -249678.827% |
| Kodiak Sciences Inc. | 181.63 Million USD | -439.075% |
| Cue Biopharma, Inc. | 14.69 Million USD | -6563.035% |
| MeiraGTx Holdings plc | 89.26 Million USD | -996.896% |
| Annexon, Inc. | 31.35 Million USD | -3022.733% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -41707.558% |
| Moderna, Inc. | - USD | -Infinity% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -52740.421% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -19976.543% |
| Blueprint Medicines Corporation | 774.12 Million USD | -26.483% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -2026.747% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -1483.896% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -2948.549% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -840.606% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -14055.458% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -3003.629% |
| Nutriband Inc. | 241.28 Thousand USD | -405699.366% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -17809.877% |
| Vor Biopharma Inc. | 35.66 Million USD | -2645.746% |
| Roivant Sciences Ltd. | 499.74 Million USD | -95.925% |
| Alkermes plc | 290.73 Million USD | -236.784% |
| ProKidney Corp. | 4.41 Million USD | -22087.469% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -79764.029% |
| Arcellx, Inc. | 97.62 Million USD | -902.953% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 43.723% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -2415.758% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -1263.562% |
| Atai Life Sciences N.V. | 16.47 Million USD | -5842.783% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -39848.372% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -144956.741% |
| MediciNova, Inc. | 215.92 Thousand USD | -453357.666% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -39143.808% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -77545.619% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -425.365% |
| Biomea Fusion, Inc. | 10.29 Million USD | -9409.839% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -27173.9% |
| Geron Corporation | 85.89 Million USD | -1039.865% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -10588.058% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -6573.935% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -3471.523% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -7887.706% |
| Royalty Pharma plc | 6.13 Billion USD | 84.041% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -7729.306% |
| Imunon, Inc. | 1.62 Million USD | -60164.945% |
| BioAtla, Inc. | 2.46 Million USD | -39702.154% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -929.355% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -17554.76% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -2794.274% |
| Structure Therapeutics Inc. | 5.45 Million USD | -17855.856% |
| 89bio, Inc. | 27.1 Million USD | -3511.971% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -5071.568% |
| aTyr Pharma, Inc. | 15.09 Million USD | -6386.472% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -8690.923% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -4551.905% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -299794.025% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -59906.006% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 34.692% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -823.153% |
| Liquidia Corporation | 3.5 Million USD | -27851.27% |
| Entera Bio Ltd. | 390 Thousand USD | -250959.744% |
| GH Research PLC | 343 Thousand USD | -285361.516% |
| Vericel Corporation | 88.14 Million USD | -1010.846% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -11127.302% |
| Xencor, Inc. | 83.43 Million USD | -1073.542% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -566944.645% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -1198642.654% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -79879.759% |
| Vaxcyte, Inc. | 29.22 Million USD | -3250.441% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -8880.4% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -10311.878% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -597052.476% |
| Portage Biotech Inc. | 47 Thousand USD | -2083161.702% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -77545.619% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -40410.261% |
| OncoCyte Corporation | 2.86 Million USD | -34028.024% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -75263.373% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -650253.362% |
| Purple Biotech Ltd. | 351 Thousand USD | -278855.271% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -4639.04% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -59133.696% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -77608.968% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -30895.03% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -170480.662% |
| United Therapeutics Corporation | 700 Million USD | -39.876% |
| HilleVax, Inc. | 51.19 Million USD | -1812.631% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -969338.614% |
| Pharming Group N.V. | 171.54 Million USD | -470.773% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -48038.323% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -18617.893% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -4490.188% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -3561.953% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -5717.784% |
| Curis, Inc. | 2.79 Million USD | -34944.13% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -45729.926% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -5752.208% |
| BeiGene, Ltd. | 930.18 Million USD | -5.262% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -85713.585% |
| Erasca, Inc. | 55.85 Million USD | -1652.865% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -39034.013% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -20983.829% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -38418.214% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -5093.513% |
| Adicet Bio, Inc. | 20.92 Million USD | -4579.473% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -120.001% |
| Aditxt, Inc. | 18.21 Million USD | -5274.54% |
| Adagene Inc. | 22.3 Million USD | -4289.379% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -6298.308% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -4724.979% |
| Compugen Ltd. | 1.35 Million USD | -72374.685% |
| Generation Bio Co. | 97.89 Million USD | -900.197% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -297508.815% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -3770.397% |
| Invivyd, Inc. | 2.16 Million USD | -45125.543% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -1731.319% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -27786733.838% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -17564.315% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -1554079.365% |
| 2seventy bio, Inc. | 256.67 Million USD | -281.471% |
| Instil Bio, Inc. | 86.05 Million USD | -1037.812% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -17346.652% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -465070.626% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -203358.322% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -5593.627% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -686.2% |
| Evaxion Biotech A/S | 10.86 Million USD | -8907.929% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -1074.175% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -1207.132% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -14972.86% |
| Cingulate Inc. | 3.13 Million USD | -31131.326% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -2388029.268% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -3527.762% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -210466.237% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -4742.638% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -62866.752% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -77608.968% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -735.488% |
| ImmunityBio, Inc. | 883.67 Million USD | -10.802% |
| Korro Bio, Inc. | 33.2 Million USD | -2848.574% |
| Kineta, Inc. | 1.31 Million USD | -74245.71% |
| BioVie Inc. | 6.11 Million USD | -15921.296% |
| Codexis, Inc. | 22.36 Million USD | -4278.166% |
| Celularity Inc. | 65.41 Million USD | -1396.756% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -970.582% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -1792.849% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -436428.31% |
| Cibus, Inc. | 24.62 Million USD | -3876.821% |
| IN8bio, Inc. | 4.89 Million USD | -19910.893% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -1204.884% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -24986.677% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 32.638% |
| Eyenovia, Inc. | 16.1 Million USD | -5978.642% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -778.225% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -99304.365% |
| Elevation Oncology, Inc. | 30.13 Million USD | -3148.94% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -8446.155% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -45462.262% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -3593.03% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -31464.571% |
| Moolec Science SA | 2.64 Million USD | -36914.217% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -3337.122% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -15409.789% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -40663.239% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -56399.308% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -849443.617% |
| Humacyte, Inc. | 58.1 Million USD | -1585.081% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -7269.66% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -38769.909% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -73078.849% |
| Notable Labs, Ltd. | 2.04 Million USD | -47685.896% |
| Immunovant, Inc. | 138 Thousand USD | -709416.667% |
| Quantum-Si incorporated | 15.3 Million USD | -6298.308% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -244683.25% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -1723.067% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -242861.042% |
| PepGen Inc. | 20.1 Million USD | -4770.339% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -21839.099% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -110411.625% |
| XOMA Corporation | 124.45 Million USD | -686.768% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -357247.81% |
| Bionomics Limited | 239.61 Million USD | -308.622% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -7275.211% |
| uniQure N.V. | 138.4 Million USD | -607.42% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -1046.217% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -94777.229% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -99304.365% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -10682.216% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -55946.537% |
| Altimmune, Inc. | 671 Thousand USD | -145821.461% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -270378.729% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -7275.211% |
| Peak Bio, Inc. | 10.72 Million USD | -9032.164% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -2189.513% |
| Benitec Biopharma Inc. | 284 Thousand USD | -344665.141% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -1057.984% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -4815.08% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -8212.531% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -4815.08% |
| argenx SE | 20 Million USD | -4795.665% |
| Immunome, Inc. | 1.65 Million USD | -59241.394% |
| Verona Pharma plc | 51.32 Million USD | -1807.563% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -9913.633% |
| Shattuck Labs, Inc. | 4.2 Million USD | -23201.594% |
| CervoMed Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -23318.632% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -167273.162% |
| Moolec Science SA | 2.64 Million USD | -36914.217% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 3.05 Million USD | -32002.721% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -373614.885% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -6781.733% |
| Achilles Therapeutics plc | 4.61 Million USD | -21116.316% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -62866.752% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -118439.104% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -161.996% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -3153.042% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -26378.326% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -235835.663% |
| Beam Therapeutics Inc. | 173.17 Million USD | -465.407% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -217.754% |
| AEON Biopharma, Inc. | 278 Thousand USD | -352106.115% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -13839.821% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -292178.507% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -915910.702% |
| NeurAxis, Inc. | 224.26 Thousand USD | -436506.171% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -1190.676% |
| Lumos Pharma, Inc. | 6.58 Million USD | -14769.142% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -5632.588% |
| Palisade Bio, Inc. | 369 Thousand USD | -265247.696% |
| Nutriband Inc. | 241.28 Thousand USD | -405699.366% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -1502.325% |
| Neurogene Inc. | 16.25 Million USD | -5923.58% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -3330.619% |
| Athira Pharma, Inc. | 1.58 Million USD | -61674.953% |
| HCW Biologics Inc. | 6.45 Million USD | -15076.175% |
| XOMA Corporation | 124.45 Million USD | -686.768% |
| Nektar Therapeutics | 230.4 Million USD | -324.969% |
| Arvinas, Inc. | 3.4 Million USD | -28698.029% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -59906.006% |
| Merus N.V. | 12.16 Million USD | -7950.756% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -662.398% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -6987.976% |
| Rezolute, Inc. | 2.22 Million USD | -43846.724% |
| Clene Inc. | 32.16 Million USD | -2944.473% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -559235.173% |
| BeyondSpring Inc. | 3.99 Million USD | -24408.961% |
| Synlogic, Inc. | 17.27 Million USD | -5567.919% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -75217.923% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -2797422.857% |
| Peak Bio, Inc. | 10.72 Million USD | -9032.164% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -1785.74% |
| Krystal Biotech, Inc. | 8.09 Million USD | -11997.024% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -453.132% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -13774.635% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -716719.919% |
| MannKind Corporation | 382.37 Million USD | -156.063% |
| Ikena Oncology, Inc. | 10.73 Million USD | -9018.393% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -239296.822% |
| Gossamer Bio, Inc. | 212.46 Million USD | -360.847% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -562620.115% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -10588.058% |
| Legend Biotech Corporation | 328.67 Million USD | -197.906% |
| Mural Oncology plc | 15 Million USD | -6423.639% |
| Disc Medicine, Inc. | 2.1 Million USD | -46503.189% |
| Champions Oncology, Inc. | 7.43 Million USD | -13078.102% |
| REGENXBIO Inc. | 89.29 Million USD | -996.576% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -114459.078% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -176964.172% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -17985.205% |
| Vaxart, Inc. | 26.51 Million USD | -3592.891% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -6153.5% |
| Cellectis S.A. | 92.85 Million USD | -954.498% |
| Longeveron Inc. | 2.04 Million USD | -47873.199% |
| Repare Therapeutics Inc. | 3.41 Million USD | -28613.578% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 29.902% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -2001.505% |
| Revolution Medicines, Inc. | 87.94 Million USD | -1013.36% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -565872.832% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -24669.365% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -308774.763% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -559404.571% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | -21.12% |
| Denali Therapeutics Inc. | 52.24 Million USD | -1774.262% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -6696.956% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -71161.499% |
| Cingulate Inc. | 3.13 Million USD | -31131.326% |
| Passage Bio, Inc. | 26.29 Million USD | -3623.789% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -14590.668% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -239883.578% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -109422.707% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -4662.088% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -39846.335% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -31252.321% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -120631.566% |
| OmniAb, Inc. | 25.56 Million USD | -3730.574% |
| Anew Medical, Inc. | 1.6 Million USD | -60905.171% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -3209.798% |
| Lipocine Inc. | 17.16 Thousand USD | -5703808.89% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -8313.241% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -2727.576% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -16475.643% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -1612.579% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -482231.527% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -18857.076% |
| Ocugen, Inc. | 6.94 Million USD | -14006.512% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -6829.953% |
| Q32 Bio Inc. | 1.31 Million USD | -74189.302% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -145604.315% |
| Alumis Inc. Common Stock | 32.58 Million USD | -2905.319% |
| Equillium, Inc. | 824 Thousand USD | -118726.82% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -10684.591% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -325403.148% |
| Dominari Holdings Inc. | 3.02 Million USD | -32235.964% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -1036162.131% |
| vTv Therapeutics Inc. | 529 Thousand USD | -184991.304% |
| Bio-Techne Corporation | 419.53 Million USD | -133.384% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -1259.982% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -405.839% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -5697.803% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -4201.612% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -16062.644% |
| Nkarta, Inc. | 88.33 Million USD | -1008.381% |
| BioCardia, Inc. | 1.31 Million USD | -74358.783% |
| Iterum Therapeutics plc | 19.5 Million USD | -4918.878% |